These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28714309)

  • 1. Characterization of Blebbistatin Inhibition of Smooth Muscle Myosin and Nonmuscle Myosin-2.
    Zhang HM; Ji HH; Ni T; Ma RN; Wang A; Li XD
    Biochemistry; 2017 Aug; 56(32):4235-4243. PubMed ID: 28714309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb.
    Ramamurthy B; Yengo CM; Straight AF; Mitchison TJ; Sweeney HL
    Biochemistry; 2004 Nov; 43(46):14832-9. PubMed ID: 15544354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates.
    Alcala DB; Haldeman BD; Brizendine RK; Krenc AK; Baker JE; Rock RS; Cremo CR
    Cell Biochem Funct; 2016 Oct; 34(7):469-474. PubMed ID: 27528075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin.
    Eddinger TJ; Meer DP; Miner AS; Meehl J; Rovner AS; Ratz PH
    J Pharmacol Exp Ther; 2007 Feb; 320(2):865-70. PubMed ID: 17132816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
    Zhang M; Rao PV
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of blebbistatin, an inhibitor of myosin II.
    Limouze J; Straight AF; Mitchison T; Sellers JR
    J Muscle Res Cell Motil; 2004; 25(4-5):337-41. PubMed ID: 15548862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blebbistatin, a myosin II inhibitor, suppresses contraction and disrupts contractile filaments organization of skinned taenia cecum from guinea pig.
    Watanabe M; Yumoto M; Tanaka H; Wang HH; Katayama T; Yoshiyama S; Black J; Thatcher SE; Kohama K
    Am J Physiol Cell Physiol; 2010 May; 298(5):C1118-26. PubMed ID: 20164381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology model of nonmuscle myosin heavy chain IIA and binding mode analysis with its inhibitor blebbistatin.
    Lv Y; Lu S; Lu T; Kou J; Yu B
    J Mol Model; 2013 Apr; 19(4):1801-10. PubMed ID: 23315199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian Nonmuscle Myosin II Binds to Anionic Phospholipids with Concomitant Dissociation of the Regulatory Light Chain.
    Liu X; Shu S; Billington N; Williamson CD; Yu S; Brzeska H; Donaldson JG; Sellers JR; Korn ED
    J Biol Chem; 2016 Nov; 291(48):24828-24837. PubMed ID: 27697842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth muscle myosin expression, isoform composition, and functional activities in rat corpus cavernosum altered by the streptozotocin-induced type 1 diabetes.
    Zhang X; Kanika ND; Melman A; DiSanto ME
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E32-42. PubMed ID: 21917637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple S100 protein isoforms and C-terminal phosphorylation contribute to the paralog-selective regulation of nonmuscle myosin 2 filaments.
    Ecsédi P; Billington N; Pálfy G; Gógl G; Kiss B; Bulyáki É; Bodor A; Sellers JR; Nyitray L
    J Biol Chem; 2018 Sep; 293(38):14850-14867. PubMed ID: 30087119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmuscle myosin is regulated during smooth muscle contraction.
    Yuen SL; Ogut O; Brozovich FV
    Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H191-9. PubMed ID: 19429828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction.
    Wang HH; Tanaka H; Qin X; Zhao T; Ye LH; Okagaki T; Katayama T; Nakamura A; Ishikawa R; Thatcher SE; Wright GL; Kohama K
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2060-8. PubMed ID: 18296570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enucleation of human erythroblasts involves non-muscle myosin IIB.
    Ubukawa K; Guo YM; Takahashi M; Hirokawa M; Michishita Y; Nara M; Tagawa H; Takahashi N; Komatsuda A; Nunomura W; Takakuwa Y; Sawada K
    Blood; 2012 Jan; 119(4):1036-44. PubMed ID: 22049517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and functional activities of smooth muscle myosin and non-muscle myosin isoforms in rat prostate.
    Chen P; Yin J; Guo YM; Xiao H; Wang XH; DiSanto ME; Zhang XH
    J Cell Mol Med; 2018 Jan; 22(1):576-588. PubMed ID: 28990332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic characterization of the sole nonmuscle myosin-2 from the model organism Drosophila melanogaster.
    Heissler SM; Chinthalapudi K; Sellers JR
    FASEB J; 2015 Apr; 29(4):1456-66. PubMed ID: 25636739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nonmuscle myosin 2A and 2B in the regulation of mesenchymal cell contact guidance.
    Zhovmer AS; Tabdanov ED; Miao H; Wen H; Chen J; Luo X; Ma X; Provenzano PP; Adelstein RS
    Mol Biol Cell; 2019 Jul; 30(16):1961-1973. PubMed ID: 31318315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmuscle myosin 2 regulates cortical stability during sprouting angiogenesis.
    Ma X; Uchida Y; Wei T; Liu C; Adams RH; Kubota Y; Gutkind JS; Mukouyama YS; Adelstein RS
    Mol Biol Cell; 2020 Aug; 31(18):1974-1987. PubMed ID: 32583739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.
    Young EJ; Blouin AM; Briggs SB; Sillivan SE; Lin L; Cameron MD; Rumbaugh G; Miller CA
    Mol Psychiatry; 2016 May; 21(5):615-23. PubMed ID: 26239291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly selective inhibition of myosin motors provides the basis of potential therapeutic application.
    Sirigu S; Hartman JJ; Planelles-Herrero VJ; Ropars V; Clancy S; Wang X; Chuang G; Qian X; Lu PP; Barrett E; Rudolph K; Royer C; Morgan BP; Stura EA; Malik FI; Houdusse AM
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7448-E7455. PubMed ID: 27815532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.